At a glance
ClinicalIndex Comparison RecordN/ACompleted· 146 enrolled
Drug / intervention
Penumbra Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The START Trial: Clinical Outcome in Acute Stroke Treatment After Imaging Guided Patient Selection for Interventional Revascularization Therapy
In Brief
A clinical study evaluating Penumbra System for Acute Ischemic Stroke. Completed, enrolled 146 participants across 1 site.
Detailed Summary
The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation between infarct volume and functional outcome in treated patients at 90 days post-procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Ischemic Stroke
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2009
Enrollment StartSep 2009
Primary CompletionSep 2016
TodayJul 2026
First PostedAug 24, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 16.9 years ago
Interventions
Penumbra Systemdevice
The Penumbra System is used to revascularize clotted cerebral blood vessels.